MedPath

Comparative Effect of 3 Different Cranberry Extracts on Cystitis Related Urinary Comfort in Women

Completed
Conditions
Recurrent Cystitis
Interventions
Dietary Supplement: Y
Dietary Supplement: Z
Dietary Supplement: X
Registration Number
NCT04962971
Lead Sponsor
CEN Biotech
Brief Summary

Urinary discomfort includes a set of signs such as an urgent need to urinate, high frequency of urination per day, discomfort / difficulty or burning sensation when urinating, smelly urine. This urinary discomfort represents in women 2 to 5% of the reasons for consultation (Berg, 1991) and can have various etiologies but the bacterial origin is the most frequent. Cranberries are traditionally used for urinary comfort and the prevention of urinary disorders with bacterial origin.

The study objective is to collect in real life efficacy and tolerance data from the consumption of 3 cranberry extracts in order to highlight the qualitative and quantitative characteristics of these extracts which are directly involved in the improvement of urinary discomfort or situation of recurrent cystitis symptomatic episodes in women.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
216
Inclusion Criteria
  • having had at least 3 symptomatic episodes of cystitis (including 1 urinary tract infection confirmed by a doctor) during the last 12 months
  • whose episode had a significant impact on quality of life / urinary discomfort (ACSS Dimension QoL ≥ 2)
  • had a smartphone compatible with Nurstrial smartphone application (e-CRF)
Exclusion Criteria
  • to be a pregnant or breastfeeding woman or planning to be pregnant within 6 months,
  • currently taking any other supplementation for urinary comfort or having taken any other cranberry-based food supplement in the past 3 months,
  • to be under antibiotic treatment or during the last 7 days preceding inclusion,
  • have urinary discomfort with a severe impact on quality of life (ACSS QoL> 7) during the last 24 hours prior to inclusion,
  • have an allergy known to plants of the cranberry family or to one of the components of the products.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cranberry extract YY404 mg per Day
Cranberry extract ZZ2090 mg per Day
Cranberry extract XX373 mg per Day
Primary Outcome Measures
NameTimeMethod
Change of the Urinary comforton weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24

Visual Analogic score

Change of the Quality of life related to urinary discomfortat weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24

ACCS Quality of life score

Secondary Outcome Measures
NameTimeMethod
Intensity of urinary disconfortEvery day during each urinary symptoms episod (Week 0 to Week 24)

Global ACCS score

Patient Global Impression of ImprovementWeek 4,Week 12,Week 24

PGI-I scale related to Urinary discomfort

Duration without antibiotic treatmenton Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24

Collection of the intake and the duration of the antibiotic treatment, if applicable

Observance of the supplementationon Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24

Total products minus remaining products

Tolerance of the supplementationWeek 4,Week 12,Week 24

Adverse events assessment

Evolution of the impact of urinary discomfort on psychosocial lifeWeek 0,Week 4,Week 12,Week 24

Likert 5 points scales

Satisfaction of the supplementationWeek 4,Week 12,Week 24

Likert 5 points scales

Trial Locations

Locations (1)

CEN Nutriment

🇫🇷

Dijon, Burgundy, France

© Copyright 2025. All Rights Reserved by MedPath